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To reduce the large amount of time spent screening, identifying, and recruiting patients into clinical trials, we 
need prescreening systems that are able to automate the data extraction and decision-making tasks that are 
typically relegated to clinical research study coordinators. However, a major obstacle is the vast amount of 
patient data available as unstructured free-form text in electronic health records. Here we propose an 
information extraction-based approach that first automatically converts unstructured text into a structured 
form. The structured data are then compared against a list of eligibility criteria using a rule-based system to 
determine which patients qualify for enrollment in a heart failure clinical trial. We show that we can achieve 
highly accurate results, with recall and precision values of 0.95 and 0.86, respectively. Our system allowed 
us to significantly reduce the time needed for prescreening patients from a few weeks to a few minutes. Our 
open-source information extraction modules are available for researchers and could be tested and validated in 
other cardiovascular trials. An approach such as the one we demonstrate here may decrease costs and 
expedite clinical trials, and could enhance the reproducibility of trials across institutions and populations. 
1. Introduction 
The creation and acceptance of electronic health records (EHRs) has ignited widespread interest in 
the use of clinical data for secondary purposes and research [1]. One such application that can 
greatly benefit from an EHR-based approach is clinical trial screening and recruitment. Clinical 
trial screening is a process that helps medical practitioners and researchers determine whether a 
particular patient is suitable for trial based on certain eligibility criteria. The eligibility criteria are 
generally divided into two parts: inclusion criteria and exclusion criteria. Inclusion criteria are 
characteristics that the prospective subjects must have if they are to be included in the study, while 
exclusion criteria are those characteristics that disqualify prospective subjects from inclusion in 
the study. 
In general, screening for clinical trial recruitment is done manually. Clinicians and study 
coordinators go through each of the eligibility criteria, determine data elements relevant to the 
clinical trial, extract the data elements from structured and unstructured EHR of each patient, and 
match the data elements with the eligibility criteria to decide whether the patient qualifies for the 
trial. Not only this process is slow, it is also prone to errors. It typically takes approximately 15 to 
20 minutes for a study coordinator to examine each patient’s data. Because of the subjectivity 
involved in human decision-making, domain knowledge, which patients are considered for initial 
search and other factors [2], there is always a possibility of type-1 and type-2 errors in the 
2	  
	  
prescreening process and biases in the overall recruitment. Furthermore, clinicians and study 
coordinators typically rely on patients identified in their own specialty clinics or in certain defined 
patient care settings, thereby missing out on the advantage of screening an entire healthcare 
system.  
We hypothesize that an automated process for prescreening would be quicker and serve as an 
independent judge of inclusion/exclusion criteria free of human bias. If the prescreening algorithm 
also has a high recall (sensitivity), it would potentially reduce recruitment bias because it would 
be possible to consider patients from a larger pool. Thus, an algorithm that can prescreen eligible 
patients efficiently could provide a proficient and robust approach to clinical trial recruitment. 
Therefore, we sought to develop a high recall (sensitivity) prescreening algorithm for recruiting 
patients into a multicenter, randomized, double-blind, parallel group, active-controlled study to 
evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in 
heart failure patients with preserved ejection fraction (PARAGON). Our approach involves 
development of information extraction modules that can be reused not only for other EHRs but 
also for other trials using similar data elements. 
2. Background 
Heart failure (HF) occurs when the heart muscle is no longer able to meet the demands of the 
body either due to reduced cardiac output or increased ventricular filling pressures. It is one of 
the most common reasons for hospital admissions among those aged 65 years and older. In 
2010 alone, HF affected 6.6 million Americans at a cost of $34.4 billion [3, 4]. Many clinical 
trials have been undertaken to find efficient solutions to the condition. However, it has been 
found that 86% of all clinical trials are delayed in patient recruitment from 1 to 6 months, and 
13% are delayed by longer than 6 months [2]. A major cause of delay in HF clinical trials is 
the inability to efficiently screen for and identify eligible patients. An automated system is 
therefore needed to accelerate the process of prescreening patients for clinical trials. 
The surge of the use of EHRs in the United States has created abundant opportunities for 
clinical and translational research. As Friedman et al noted, the extensive use of clinical data 
provides great potential to transform our healthcare system into a “Self-learning Health 
System” [5, 6]. In addition to its primary purpose of providing improved clinical practice, the 
use of EHRs offers means for the identification of participants who satisfy predefined criteria. 
This can be used for a variety of applications, including clinical trial recruitment, outcome 
prediction, survival analysis, and other retrospective studies [7-10].  
EHRs contain patient data in both structured and unstructured formats. The structured data 
generally encompass a patient’s demographic data, physical characteristics (e.g., body mass index 
[BMI], blood pressure), laboratory data, and diagnoses. Structured data are not only the best 
representation of knowledge but also easier to process. However, there is a vast amount of medical 
knowledge that is locked in the unstructured format. The unstructured data are typically text 
clinical narratives present in progress notes, imaging reports (e.g., echocardiographic reports), and 
discharge summaries, for example. Thus, a module that can automatically and efficiently extract 
information from unstructured clinical text and convert it into a structured form is needed. 
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The syndromic nature of HF presents unique challenges for the identification of patients 
from EHR data for research [11]. HF with preserved ejection fraction, in which the global 
pumping function of the heart is normal, is particularly challenging to identify during 
prescreening activities. The presence of large amounts of unstructured data in patient medical 
reports aggravates the challenges. Previous studies have shown that clinicians often prefer free 
text entry to coded options, in order to fully explain the health conditions of each patients [12-
14]. It has also been noted that unstructured data are essential because of the information they 
contain [15]; therefore, unstructured data are likely to persist in the future. There is an 
immediate need for an automated data extraction system to transform unstructured clinical 
reports into a structured form, which is much easier to process and handle [16-18]. 
There has been considerable research in identifying patient cohorts from EHRs [19]. These 
approaches can be categorized into three general types: (1) rule-based approaches [20-24], (2) 
machine learning–based approaches [25-28], and (3) information retrieval–based approaches 
[29-32]. All these approaches use either pattern matching (regular expressions) or language 
modeling–based methods [33-36] to extract features for their system to work on. Rule-based 
systems are stringent and binary (either yes or no) in nature. On the other hand, machine 
learning– and information retrieval–based methods provide output as probability or a score. 
Machine learning techniques, however, require a large amount of training data to give accurate 
results. 
Our proposed system is different from these approaches in various ways. A majority of the 
reported systems aim to identify whether a patient shows a certain phenotype. Therefore, the 
number of criteria required is less than that which are necessary for clinical trial screening. For 
example, a majority of the systems only use a variation of disease names, medications used, or 
treatments taken as their eligibility criteria [21, 23]. Ours is a more diverse application. Our 
goal is to check whether a particular patient qualifies for a certain clinical trial. Clinical trials 
usually have a large number of eligibility criteria that need to be checked. Therefore, a large 
amount of information related to the eligibility criteria needs to be extracted.  
Our study goal is similar to that of the plethora of approaches proposed in computer-based 
clinical trial recruitment systems [37]. However, a majority of these approaches either lack 
EHRs as data source or are not equipped to handle unstructured data. We, on the other hand, 
obtain patient data from EHRs and handle unstructured data through information extraction 
methods, as opposed to the “bag of terms” or “bag of concepts” suggested in other methods 
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Figure 1. Summary of techniques for patient cohort identification. 
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[38]. The main contributions of our study are to (1) show that automated recruitment systems 
can only serve as prescreening tools and to (2) develop and validate a clinical trial screening 
system based on information extracted from EHRs. Here, we demonstrate how our system 
processes a set of eligibility criteria, extracts information from patient records automatically 
into a structured format, and finally prescreens the patients who could qualify for the trial by 
matching the structured patient document with the eligibility criteria.  
Section 3 describes the data and the algorithm used to convert the data into a structured 
form. We present our results in Section 4, discuss our experience and the challenges faced in 
Section 5, and then conclude in Section 6.  
 
3. Methods 
3.1. Patient Records and Eligibility Criteria – Data Description 
The patient records used in this study come from the EPIC EHR used by Northwestern Memorial 
Group. The initial cohort of patients we have considered for our experiments was very broad to 
ensure we were not missing any patients that could be included – patients that currently have been 
documented to have HF with the ICD-9-CM Diagnosis Code 428.0 or had an echocardiogram 
within the past year. We selected 198 of these patients for development and 3002 patients for 
validation.  
Each patient’s data consists of five types of reports: encounters, problem list, 
echocardiography reports, lab reports, and current medication list. Encounters contain two types of 
files: encounter diagnosis name and encounter progress notes. The characteristics of the patient 
records for both datasets are summarized in Table 1. We have 40 eligibility criteria – 7 for 
inclusion and 33 for exclusion – for the PARAGON clinical trial [39]. However, we currently 
evaluate our approach based on a subset of these criteria (Figure 3).  
Patient	  Before	  
Demographics,	  Lab	  
Values,	  etc.	  
(Structured	  Data)	  
Pathology	  Reports,	  
Echo	  Report,	  
Encounter	  Notes,	  
Discharge	  
Summaries,	  etc.	  
(Unstructured	  Data)	  
Information	  
Extraction	  
Modules	  
Demographics	  
	  	  	  	  Patient	  After	  
Lab	  Values	  
Pathology	  Report	  
Information	  
Echo	  Report	  
Information	  
Encounter	  Notes	  
Information	  
(All	  Structured	  
Form)	  
Eligibility	  
Criteria	   OUTPUT	  
Figure 2. Overview of our clinical trial recruitment system architecture.	  We have analyzed different HF- 
related patient medical reports and derived pattern-based Information extraction modules that provide output of 
structured data to compare against eligibility criteria for clinical trial recruitment 
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Table 1. Characteristics of the development and validation patient datasets.	  
	   	   Development	  set	  	   Validation	  set	  
Total	  number	  of	  patients	   198	   3002	  
Encounters	   54,173	   393,482	  
Echocardiography	  reports	   96,281	   883,385	  
Lab	  reports	   52,393	   371,879	  
Current	  medication	  entries	   4490	   41,947	  
Problem	  lists	   3521	   33,089	  
LVEF	  
Encounter	  
Progress	  Notes	  
Encounter	  
Diagnosis	  Names	  
Problem	  List	  
Lab	  Report	  
Echo	  Report	  
Medication	  List	  
IC:	  Age	  ≥	  55	  y,	  EC:	  BMI	  >	  40	  kg/m2	  
IC:	  Number	  of	  HF	  terms	  ≥1	  
IC:	  LVEF	  value	  ≥45%	  
EC:	  Number	  of	  angioedema	  or	  
pancreatitis	  or	  bilateral	  renal	  artery	  
stenosis	  terms	  ≥1	  
EC:	  Number	  of	  “transplant”	  or	  “ICD”	  
terms	  ≥1	  
EC:	  Hb	  <	  10	  g/dl,	  GFR	  <	  30	  
EC:	  Sentences	  with	  “malignant”	  term	  
and	  absence	  of	  “basal”	  and	  
“prostrate”	  terms	  ≥1	  
EC:	  SBP	  value	  >	  150	  mm	  Hg	  and	  
number	  of	  antihypertensive	  drugs	  >	  3	  
EC:	  Number	  of	  “pericardial	  
constriction”	  or	  “genetic	  
hypertrophic	  cardiomyopathy”	  or	  
“infiltrative	  cardiomyopathy”	  terms	  ≥	  
1	  
Patient	  Records	  
Data	  
Structured	   data	  
normalizer	  
Structured	   data	  
extractor	  
Unstructured	  
data	  extractor	  
Age	  
BMI	  
Hb	  
GFR	  
BP	  
a.	  Heart	  failure	  
b.	  Angioedema	  
c.	  Pancreatitis	  
d.	  Organ	  transplant	  
e.	  ICD	  
f.	  Malignant	  cancer	  
g.	  Valvular	  heart	  
disease	  
h.	  Pericardial	  
constriction.	  
Cardiomyopathy	  
Figure 3. Algorithm. Each patient's data parsed through three types of extraction module. The modules extract the appropriate 
information and create a patient profile. This profile is then checked against the clinical trial eligibility criteria to check the 
patient’s qualification. (BMI=Body Mass Index, Hb = Hemoglobin, GFR=Glomerular Filtration Rate, BP = Blood Pressure, 
LVEF=	  left ventricular ejection fraction, ICD=	  implantable cardioverter defibrillators, IC=Inclusion criteria, EC=Exclusion 
criteria) 
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3.2 Algorithm 
The information from the patient data is extracted as part of separate modules. These modules are 
designed to extract the data elements relevant to PARAGON but are reusable individually for 
other clinical trials. After extraction, a rule-based system matches the eligibility criteria and 
discards patients who do not satisfy any of the inclusion criteria or satisfies one of the exclusion 
criteria. Figure 3 describes the system’s architecture in finer detail. We broadly categorize the 
modules as: (1) structured data normalizer, (2) unstructured data extractor, and (3) unstructured 
data classifier. 
Structured data normalizer is used for the extraction of data elements whose values are 
already present in the structured form. This module is further divided into two submodules. In 
submodule 1, we extract the values for age, BMI, hemoglobin, GFR and blood pressure from 
structured fields. In submodule 2, we extract the number of medications a patient belong to 
different drug classes. The reports are in structured form with mapping of the medication to the 
patient. This submodule requires external information resources, which we provide as databases to 
our system. Table 2 and Table 3 list the drug classes that we incorporated for the PARAGON 
clinical trial.  
Table 2. Types of antihypertensive drugs 
Beta	  (β)-­‐	  
blockers	  	  
Dihydropyridines	  	   Nondihydropyridines:	  class	  IV	  
antiarrhythmics	  
Antihypertensives	  
(others)	  
Acebutolol	   Amlodipine	   Diltiazem	   Aliskiren	  
Atenolol	   Felodipine	   Verapamil	   Fenoldopam	  
Betaxolol	   Nicardipine	   	   Hydralazine	  
Bisoprolol	   Nifedipine	   	   Hydralazine/HCTZ	  
Carvedilol	   Nisoldipine	   	   Methyldopa/HCTZ	  
Esmolol	   	   	   Minoxidil	  
 
Table 3. Common angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) 
Common	  ACE	  Inhibitors	   Common	  ARBs	  
Benazepril	   Candesartan	  
Captopril	   Eprosartan	  
Enalapril	   Irbesartan	  
Fosinopril	   Losartan	  
Lisinopril	   Olmesartan	  
Unstructured data extractor is used for the extraction of values of data elements present in 
unstructured text. This module also accepts input and provides output just as the previous module 
but uses a complex set of regular expressions to extract the exact value. For example, we currently 
extract the left ventricular ejection fraction (LVEF) value for our clinical trial. For this, we first 
use a set of regular expressions to extract sentences where the LVEF value may be present and 
then another set of regular expressions to extract the definite values as shown in Table 4. Regular 
expressions 1 through 4 extract the sentences that can contain LVEF values. Then, the sentences 
are parsed through regular expressions 5 and 6. Regular expression 5 extracts the values present in 
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range format: for example, “40% to/- 45%.” Regular expression 6 extracts the freely available 
values: for example, “40%.”  
 
 
Table 4. Regular expressions for extracting LVEF-containing sentences and values. 
S/N	   Regular	  Expression	  
1	   (left	  ventricular	  ejection	   fraction|lvef|lv	  ejection	   fraction|left	  ventricle	  ejection	   fraction|ejection	   fraction|	  
ef	  |ejection	  fraction)[^_%\\.]*?([\\d-­‐\\.]+)\\s*'?%	  
2	   (left	   ventricular	   systolic	   function|left	   ventricular	   function|systolic	   function	   of	   the	   left	   ventricle|lv	   systolic	  
function|left	   ventricular	   ejection	   fraction|ejection	   fraction|left	   ventricle)(normal|normal	   global|low	  
normal|well	   preserved|severely	   reduced|moderately	   decreased|moderately	   depressed|severely	  
decreased|severe|markedly	   decreased|markedly	   reduced|severely	   globally	   reduced|mildly	  
decreased|mildly	  depressed|severely	  depressed)	  
3	   (normal|normal	   global|low	   normal|well	   preserved|severely	   reduced|moderately	   decreased|moderately	  
depressed|severely	   decreased|severe|markedly	   decreased|markedly	   reduced|severely	   globally	  
reduced|mildly	  decreased|mildly	  depressed|severely	  depressed)	  
4	   .*(moderate|marked|severe)	   (lv	   systolic	   dysfunction|left	   ventricular	   dysfunction|left	   ventricular	   systolic	  
dysfunction).*	  
5	   ((\\d+\\s*(\\-­‐|to)\\s*\\d+)|(\\d*\\.\\d*\\s*(\\-­‐|to)\\s*\\d*\\.\\d*)|(\\d*\\.\\d+)|(\\d+))(?=(\\s*(\\%)))	  
6	   \\d+(\\.\\d+)?	  
Unstructured data classifier is used for classifying whether certain data elements are present 
or absent in relation to the context of the patient. Currently in this module, we extract all the 
instances of a given data element (diagnosis, medication, treatment, or tests) and its synonyms in 
the input report(s). For this, the module first checks for synonyms of the input term using UMLS 
Metathesaurus [40], builds automatically a set of regular expressions, and then applies them to the 
input report text to extract all the instances. For example, to extract HF-related terms the module 
compiles a list of synonyms: “heart failure,” “HF,” “diastolic dysfunction,” and 
“cardiomyopathy.” Next, a set of regular expressions are automatically generated (Table 5) and 
used to extract all the instances of HF-related terms. For PARAGON, the other data elements 
processed in this category are “angioedema”, “pancreatitis”, “valvular heart disease,” etc. We 
adapt existing rule-based systems to make sure the data elements are not in their negated form 
using a rule-based negation detection algorithm, the data elements refer to the current status (as 
opposed to historical condition or a hypothesis for conducting a test) and the data elements 
correspond to the patient (as opposed to a family member or relative) [41, 42].   
 Table 5. Regular expressions to extract HF-related terms. 
Regular	  Expression	  
[^\w]+(h|H)eart\s+(f|F)ailure[^\w]+	  
[^\w]+(d|D)iastolic\s+(d|D)ysfunction[^\w]+	  
[^\w]+(c|C)ardiomyopathy[^\w]+	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[^\w]+HF[^\w]+	  
 
 
 
4. Evaluation and Results 
 We first evaluated our methods iteratively using the development set of 198 patient reports. A 
study coordinator read each patient record, extracted data elements of relevance to PARAGON, 
and matched against the eligibility criteria. For the 198 patient reports, our experienced research 
coordinator took two weeks (80 hours) to generate the gold standard data. Finally, we had 40 of 
the 198 patients (20%) prescreened for further analysis according to the eligibility criteria. After 
consulting a cardiologist, the number of patients finally found eligible was 12. The sheer size of 
the data that the clinical investigator or research coordinator has to read through is time 
consuming as well as tedious (Table 1). 
The number of patients finally qualifying for any clinical trial is always small. This is mostly 
due to the large number of stringent eligibility criteria. Therefore, it becomes important for an 
automated system to give more importance to retrieving nearly all the qualifying patients; in other 
words, the recall of the system should be close to 100%. We tuned our system in order to achieve 
a high recall (i.e., high sensitivity) so as not to have too many false negatives (which would result 
in missing potentially eligible patients). On the experiments run on the development dataset, we 
achieved close to 95% recall with a precision of 86% (F-score of 90%). Table 6 presents further 
details. 
Table 6.  Outputs for the development dataset. 
 
 
 
 
 
 
 
On the validation dataset, we prescreened 113 (3.7%) patients for the PARAGON clinical 
trial. Our clinical trial study coordinator went through these records and found that 21 of the 
patients fully qualify for the clinical trial. Twenty-five of the patients require consultation with a 
cardiologist. However, 67 of the patients do not qualify for the trial. In most cases, this is not 
because of errors in the prescreening system but due to certain other criteria that have either been 
not included in the algorithm (for example, certain specific allergies to medication, pregnancy, 
patient not present in the country, etc.) or are beyond the scope of any system to check due to lack 
of data (for example, type of cancer or cancer is malignant or benign when the details are not 
present). We detail some these issues in the Discussion section.  
	   Prescreening	  Gold	  Standard	  
(Manual)	  
Patients	  Included	  	   Patients	  Excluded	  
Classification	  	  
outcome	  
(algorithmic)	  
Patients	  included	   38	   6	  
Patients	  excluded	   2	   152	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Table 7 lists the number of patients we discard based on each criteria for both the development 
and validation dataset. It can be seen that each information extraction module played a major role 
in screening out large proportions of patients without human involvement. For example, module 2, 
which extracts LVEF values, discarded 90 patients from the 198-patient development dataset and 
672 patients from the 3002-patient validation dataset. This would not have been captured by any 
methods that aim to prioritize patients using information retrieval approaches without first 
extracting the values of the relevant data elements from unstructured reports. 
Table 7. Number of patients discarded at each step for the 198- and 3002-patient datasets 
Criterion	  based	  on	   Report	  Type	   Number	  of	  Patients	  
Discarded	  
Age	  +	  BMI	   Encounter	  report	   22	   1071	  
HF	  related	  term	   Encounter	  report/problem	  list	   3	   1597	  
LVEF	   Echo	  report	   90	   672	  
Angioedema,	  Pancreatitis	  or	  Bilateral	  
Renal	  Artery	  stenosis	  
Encounter	  report	   44	   218	  
Organ	  Transplant	  or	  ICD	   Encounter	  report/problem	  list	   50	   806	  
Malignant	  organ	  system	   Encounter	  report/problem	  list	   49	   600	  
Hb	  +	  GFR	   Lab	  value	  report	   42	   507	  
Blood	  Pressure	  and	  Hypertensive	  drugs	   Encounter	  report	   6	   522	  
Pericardial	  constriction	  or	  genetic	  
hypertrophic	  cardiomyopathy	  or	  
infiltrative	  cardiomyopathy	  
Echo	  report	   23	   314	  
The time taken by our system to successfully parse and extract the required information from 
different data reports is just 2 minutes (for the whole 198-patient dataset). For 3002 patients, we 
are able to do so in approximately 20 minutes. Our clinical trial coordinator took almost two 
weeks to go through each of 198 patients’ reports. Thus, the time required for her to go through 
3002 patients would have been several months. Instead, she only had to examine the 113 
prescreened patients from our system, which only took one week. This demonstrates the 
usefulness of our system in practical application. However, from these results and observations, 
we also understand that the system can only be used for prescreening, and further validation by the 
clinical trial study coordinator or clinical investigator is still required. 
5. Discussion 
We achieved high recall with reasonable precision on our development dataset and were able to 
replicate the performance on a larger dataset. As with any automated system, there are certain 
limitations to our proposed architecture, which can be broadly categorized into (1) data processing 
and (2) data-handling issues. We briefly describe some of these issues. The precision of the 
system suffers from the complexity of text data. In some cases current unstructured data extractor 
module is unable to extract terms correctly. For example, the module fails to identify certain HF 
or ICD related terms. This is due to large number of synonyms and spelling mistakes for the 
relevant data elements. 
As mentioned earlier, there are some cases where a patient has certain allergies or may show a 
certain adverse reaction to a medication, both of which are difficult to extract from unstructured 
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notes because they are not always reported in a standard format within the EHR. There are also 
cases where the patient has moved out of the hospital’s geographic area and therefore cannot 
provide consent for the clinical trial. These are details that are too patient-specific for automated 
extraction and can only be checked manually.  
In some cases, the LVEF value (which is an important factor for inclusion in HF clinical trials) 
is present in the form of a range or qualitative description. This created a problem while checking 
for eligibility according to the criterion given. For example, in our clinical trial, we have set the 
lower limit of LVEF at 45% based on the inclusion criteria. This creates a problem when the value 
is contained within the range extracted (40% to 45% or 30% to 50%, for example). Our initial 
approach was to take the average value and compare it with the threshold. However, after 
consultation with the cardiologist, our approach was deemed inappropriate. Therefore, we 
subsequently modified our algorithm to include these patients but with a warning regarding their 
LVEF value. This then served as an indication to the study coordinators to recheck the 
echocardiogram report (and review the echocardiographic images with the clinical investigator) in 
order to make further decisions about the patient’s eligibility for the clinical trial. 
There are also some cases where the clinicians are just screening the patient for a particular 
diagnosis but the patient may not actually have the disease, such as a “malignancy of organ 
system” check of exclusion criteria. To handle this, we do not discard those patients if we find the 
“screening” term in the sentences extracted for eligibility check. In similar cases, we also see the 
term “cancer” instead of “malignancy.” However, we cannot discard all patients with the “cancer” 
term present since some can have a benign diagnosis and not be malignant, and it is impossible for 
our system to decide if the cancer is malignant or relatively benign. To mitigate these issues, we 
currently just display a warning in these cases, as we did for LVEF. The coordinator can then 
perform further checks and decide the classification. In other exclusion criterion where we have to 
check the B-type natriuretic peptide and glomerular filtration rate values, we face the issues of 
non-availability and potential outliers in the data. For such cases too, we currently report them as a 
warning to coordinators for further checking. 
We also had to deal with data-handling issues in some cases. For example, in criteria where 
we have to perform a check for recent hemoglobin values, we found that the value may also be 
present in reports other than just blood reports. To mitigate this issue, we check for hemoglobin 
values in all reports and then extract the most recent one. Similarly, there were also cases where 
“end-date” of medication and “department-name” for encounter reports were missing or 
misplaced. We handled such cases following discussions with the data warehouse coordinator. To 
summarize, we can deduce that the patient data records are noisy due to various reasons and a 
preprocessing module is required to handle these issues. 
6. Conclusions and Future Work 
We have presented here a new method for automated clinical trial recruitment system. We have 
shown, through our results and discussion, that any automated recruitment system suffices as a 
prescreening process that significantly reduces the workload in recruiting patients, even if it 
cannot completely replace manual intervention. Our system works on the hypothesis that the 
performance can be greatly enhanced by converting unstructured free clinical text into a structured 
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form. To validate our hypothesis, we built modules that extract key data elements from the 
unstructured text on the basis of given eligibility criteria. We evaluated our system on two 
datasets: one of 198 patients and one of 3002 patients. Our experiments show highly favorable 
results and affirm our hypothesis. For future research, we aim to evaluate the reproducibility of 
our system for PARAGON trial at other institutions. We also intend to build further modules to 
use the framework for other clinical trials.  
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